Furosemide

105 interactions 5 explained in plain English
Also sold as: Disal Furoscix Lasix Salix - substance
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Furosemide Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Enalapril Epaned An increased risk of severe hypotension and deterioration in renal function, including renal failure Details Furosemide Eprosartan Teveten® Severe hypotension and deterioration in renal function, including renal failure Details Furosemide Etodolac Lodine Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Exenatide Injection Bydureon An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Fenoprofen Fenopron Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Fentanyl Transdermal Patch Duragesic® Reduced diuretic efficacy Details Furosemide Flurbiprofen Ansaid Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Flurbiprofen Ophthalmic Ocufen Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Foscarnet Injection Foscavir Impaired foscarnet elimination and potential for toxicity Details Furosemide Fosinopril Monopril® An increased risk of severe hypotension and deterioration in renal function, including renal failure Details Furosemide Gentamicin Injection Garamycin® I.V. Increased gentamicin plasma and tissue concentrations and additive ototoxicity and/or nephrotoxicity Details Furosemide Gentamicin Ophthalmic Garamycin® Ophthalmic Increased gentamicin plasma and tissue concentrations and additive ototoxicity and/or nephrotoxicity Details Furosemide Gentamicin Topical Garamycin® Increased gentamicin plasma and tissue concentrations and additive ototoxicity and/or nephrotoxicity Details Furosemide Glimepiride Amaryl An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Glipizide Glucotrol An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Hydromorphone Injection Dilaudid Reduced efficacy of diuretics Details Furosemide Hydromorphone Rectal available generically Reduced efficacy of diuretics Details Furosemide Ibuprofen Addaprin Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Insulin Degludec (Rdna Origin) Injection Ryzodeg® (as a combination product containing Insulin Degludec and Insulin Aspart) An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Insulin Detemir (Rdna Origin) Injection Levemir An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Insulin Glulisine (Rdna Origin) Injection Apidra An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Irbesartan Avapro Severe hypotension and deterioration in renal function, including renal failure Details Furosemide Ketoprofen Actron® Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Ketorolac Acular Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Ketorolac Injection Acular Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Ketorolac Nasal Spray Sprix Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Ketorolac Ophthalmic Acular Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Leflunomide Arava Increased exposure of OAT3 substrate Details Furosemide Levothyroxine Ermeza Increased risk of free thyroid hormones, followed by an overall decrease in total thyroid hormone levels Details Furosemide Linagliptin Tradjenta An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Liothyronine Cytomel Increased risk of free thyroid hormones, followed by an overall decrease in total thyroid hormone levels Details Furosemide Liraglutide Injection Saxenda An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Lithium Carbonate Lithobid An increased risk of lithium toxicity Details Furosemide Lixisenatide Injection Adlyxin® An increased risk of hyperglycemia and an increased insulin requirement Details Furosemide Losartan Arbli Severe hypotension and deterioration in renal function, including renal failure Details Furosemide Meclofenamate Meclodium® Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Mefenamic Acid Ponstel® Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Meloxicam Alloxate Reduced diuretic effectiveness and possible nephrotoxicity Details Furosemide Meloxicam Injection Alloxate Reduced diuretic effectiveness and possible nephrotoxicity Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.